Nanomedicine in Lung Cancer Immunotherapy
Frontiers in Bioengineering and Biotechnology · 17.03.2023 · 11
DOI: 10.3389/fbioe.2023.1144653 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 17.03.2023. Verfasst von Mohammad Doroudian und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Trinity College, Trinity Biomedical Sciences Institute, Dublin, Ireland. Die Arbeit wurde bisher 54-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer is the major cause of cancer death worldwide. Cancer immunotherapy has been introduced as a promising and effective treatment that can improve the immune system’s ability to eliminate cancer cells and help establish immunological memory. Nanoparticles can contribute to the rapidly evolving field of immunotherapy by simultaneously delivering a variety of immunological agents to the target site and tumor microenvironment. Nano drug delivery systems can precisely target biological pathways and be implemented to reprogram or regulate immune responses. Numerous investigations have been conducted to employ different types of nanoparticles for immunotherapy of lung cancer. Nano-based immunotherapy adds a strong tool to the diverse collection of cancer therapies. This review briefly summarizes the remarkable potential opportunities for nanoparticles in lung cancer immunotherapy and its challenges.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine, Trinity College, Trinity Biomedical Sciences Institute, Dublin, Ireland.
- Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
- Department of Clinical Medicine, Trinity College Dublin, Tallaght University Hospital, Dublin, Ireland.
Zitieren
APA
Doroudian, M., Zanganeh, S., Abbasgholinejad, E., & Donnelly, S. C. (2023). Nanomedicine in Lung Cancer Immunotherapy. Frontiers in Bioengineering and Biotechnology, 11. https://doi.org/10.3389/fbioe.2023.1144653
Vancouver
Doroudian M, Zanganeh S, Abbasgholinejad E, Donnelly SC. Nanomedicine in Lung Cancer Immunotherapy. Frontiers in Bioengineering and Biotechnology. 2023;11. doi:10.3389/fbioe.2023.1144653
BibTeX
@article{Doroudian2023,
author = {Doroudian, Mohammad and Zanganeh, Saba and Abbasgholinejad, Elham and Donnelly, Seamas C},
title = {Nanomedicine in Lung Cancer Immunotherapy},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2023},
volume = {11},
doi = {10.3389/fbioe.2023.1144653}
}
EUVIMED